The global anesthesia and respiratory devices market size is accounted at USD 50.45 billion in 2025 and is forecasted to hit around USD 90.18 billion by 2034, representing a CAGR of 6.64% from 2025 to 2034. The North America anesthesia and respiratory devices market size was estimated at USD 12.33 billion in 2024 and is expanding at a CAGR of 6.84% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Anesthesia and Respiratory Devices Market, by Product Type, 2024-2033
7.1.1. Anesthesia Devices
7.1.1.1. Machines
7.1.1.2. Disposables
7.1.1.3. Market Revenue and Forecast (2021-2033)
7.1.2. Respiratory Devices
7.1.2.1. Disposables
7.1.2.2. Equipment
7.1.2.3. Oxygen Concentrators
7.1.2.4. Market Revenue and Forecast (2021-2033)
7.1.3. Measurement Devices
7.1.3.1. Spirometers
7.1.3.2. Pulse Oximeters
7.1.3.3. Capnography
7.1.3.4. Peak Flow Meters
7.1.3.5. Market Revenue and Forecast (2021-2033)
8.1. North America
8.1.1. Market Revenue and Forecast, by Product (2021-2033)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, by Product (2021-2033)
8.2. Europe
8.2.1. Market Revenue and Forecast, by Product (2021-2033)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, by Product (2021-2033)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, by Product (2021-2033)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, by Product (2021-2033)
8.3. APAC
8.3.1. Market Revenue and Forecast, by Product (2021-2033)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, by Product (2021-2033)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, by Product (2021-2033)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, by Product (2021-2033)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
8.4. MEA
8.4.1. Market Revenue and Forecast, by Product (2021-2033)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, by Product (2021-2033)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, by Product (2021-2033)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, by Product (2021-2033)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
8.5. Latin America
8.5.1. Market Revenue and Forecast, by Product (2021-2033)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, by Product (2021-2033)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.1. Masimo Corporation
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Medtronic
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. AirSep Corporation
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Smiths Medical
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. GE Healthcare
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Philips Healthcare
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. B. Braun Medical Inc.
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Drägerwerk AG & Co
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9. KGaA
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. Getinge AB
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
9.11. Teleflex Inc
9.11.1. Company Overview
9.11.2. Product Offerings
9.11.3. Financial Performance
9.11.4. Recent Initiatives
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
11.1. About Us
11.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample